High Prevalence of Iron Deficiency in Patients with Acute Decompensated Heart Failure
Alain Cohen‐Solal(Hôpital Lariboisière), Alexandre Mebazaa(Délégation Paris 5), Olivier Hanon(Université Paris Cité), Bernadette Darné(Twitter (United States)), Mohamed Terbah(Centre hospitalier universitaire d'Orléans), Christophe Leclercq(Hôpital Pontchaillou), Faı̈ez Zannad(Centre d’Investigation Clinique Innovation Technologique de Nancy), Ladan Duvillié(Vifor Pharma (United Kingdom)), Thierry Laperche(Centre Cardiologique du Nord), Thibaud Damy(Inserm), Sébastien Kerebel(Hôpital d'Instruction des Armées Sainte-Anne), Stefan D. Anker(Deutsches Herzzentrum der Charité), J.-P. Baguet(Université Grenoble Alpes), Victor Concas(Vifor Pharma (United Kingdom))
Cited by 153
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k